Article Versions Notes

Köhler N, Karaköse H, Grobbel H-P, Hillemann D, Andres S, König C, Kalsdorf B, Brehm TT, Böttcher L, Friesen I, et al. A Single-Run HPLC–MS Multiplex Assay for Therapeutic Drug Monitoring of Relevant First- and Second-Line Antibiotics in the Treatment of Drug-Resistant Tuberculosis. Pharmaceutics. 2023; 15(11):2543. https://doi.org/10.3390/pharmaceutics15112543

Köhler, Niklas, Hande Karaköse, Hans-Peter Grobbel, Doris Hillemann, Sönke Andres, Christina König, Barbara Kalsdorf, Thomas Theo Brehm, Laura Böttcher, Inna Friesen, and et al. 2023. "A Single-Run HPLC–MS Multiplex Assay for Therapeutic Drug Monitoring of Relevant First- and Second-Line Antibiotics in the Treatment of Drug-Resistant Tuberculosis" Pharmaceutics 15, no. 11: 2543. https://doi.org/10.3390/pharmaceutics15112543

Köhler, N., Karaköse, H., Grobbel, H.-P., Hillemann, D., Andres, S., König, C., Kalsdorf, B., Brehm, T. T., Böttcher, L., Friesen, I., Hoffmann, H., Strelec, D., Schaub, D., Peloquin, C. A., Schmiedel, S., Decosterd, L. A., Choong, E., Wicha, S. G., Aarnoutse, R. E., ... Sánchez Carballo, P. M. (2023). A Single-Run HPLC–MS Multiplex Assay for Therapeutic Drug Monitoring of Relevant First- and Second-Line Antibiotics in the Treatment of Drug-Resistant Tuberculosis. Pharmaceutics, 15(11), 2543. https://doi.org/10.3390/pharmaceutics15112543